documents: FDA-2014-D-1814-0124
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2014-D-1814-0124 | FDA | FDA-2014-D-1814 | Supplemental Comment from Verax Biomedical Incorporated | Other | Supplemental Comment | 2017-08-16T04:00:00Z | 2017 | 8 | 2017-08-16T04:00:00Z | 2017-08-16T13:56:18Z | 0 | 0 | 0900006482a3613c |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref